A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

Hideo Baba, Naoko Hayashi, Yasunori Emi, Yoshihiro Kakeji, Akinori Egashira, Eiji Oki, Ken Shirabe, Tetsuo Toyama, Takefumi Ohga, Manabu Yamamoto, Hirofumi Hasegawa, Fumiko Kohakura, Hidefumi Higashi, Kiyoshi Niwa, Fumihiko Fujita, Yutaka Ogata, Shunji Kohnoe, Masafumi Inomata, Hironori Samura, Shoji TokunagaYoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience'. Together they form a unique fingerprint.

Medicine & Life Sciences